Implantable collamer lens market seen growing to $28.74 billion by 2030

The global implantable collamer lens market is projected to rise from $22.2 billion in 2026 to $28.74 billion by 2030, according to a new market report from The Business Research Company. Growth is tied to rising vision disorders, demand for minimally invasive eye surgery and broader adoption of premium vision correction options.

Why it matters: - Implantable collamer lenses are becoming a bigger part of the refractive surgery market as more patients look for alternatives to glasses, contacts and LASIK. - The market outlook suggests continued demand for minimally invasive, reversible vision correction procedures. - Rising vision impairment worldwide gives eye-care providers a larger patient pool for these implants.

What happened: - The Business Research Company released its "Implantable Collamer Lens Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035." - The report projects the market will grow from $20.77 billion in 2025 to $22.2 billion in 2026. - The report forecasts the market will reach $28.74 billion by 2030. - The forecast implies a 6.7% compound annual growth rate from 2026 to 2030. - The release was published Aug. 11, 2026, from London. - The report offers a free sample and the full report.

The details: - Implantable collamer lenses are refractive lens implants placed inside the eye. - The lenses sit behind the iris and in front of the natural lens. - The implants are used to correct myopia, hyperopia and astigmatism. - The procedure is positioned as a reversible alternative to LASIK and other refractive surgeries. - Market growth is linked to rising prevalence of refractive vision disorders, growing demand for surgical vision correction and broader acceptance of ICL procedures. - The report also cites technological progress in ophthalmic implants and the expansion of specialized ophthalmic clinics. - Future growth is expected to come from premium vision correction options, minimally invasive ophthalmic surgeries, elective eye care procedures, advanced ophthalmology investments and greater patient awareness. - Key trends include wider use of EVO implantable collamer lenses, laser-assisted implantation techniques, customizable lens designs and a focus on long-term visual stability.

Between the lines: - The market forecast reflects a broader shift toward elective procedures that promise precision and reversibility. - World Health Organization data cited in the release underscores the size of the opportunity: more than 2.2 billion people globally live with vision impairment, and 1 billion cases are preventable or untreated. - North America held the largest share of the global market in 2025, while Asia-Pacific is expected to be the fastest-growing region. - The regional mix points to mature demand in developed health systems and faster expansion in populous Asian markets. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

What's next: - The market is expected to keep expanding through 2030 as adoption of premium and minimally invasive eye-care treatments increases. - Demand may rise as more clinics and technology providers push newer lens designs and implantation techniques. - The Business Research Company said its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel dashboards, market hotspot infographics and updated trend analysis.

The bottom line: - Implantable collamer lenses are moving from a niche option toward a larger global eye-care category, with growth driven by both medical need and patient preference for less invasive vision correction.